![Kristina Meyer](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Kristina Meyer
Geen lopende functies
Vermogen: 162 607 $ op 31-05-2026
Profiel
Kristina Meyer formerly worked at Sertant, Inc., as Director-Business Developments from 2002 to 2004, Thieme Medical Publishers, Inc., as Director-Business Development, Oxford BioTherapeutics Ltd., as Vice President-Business Development from 2013 to 2015, Evotec (UK) Ltd., as Vice President-Business Development from 2005 to 2013, and Inventiva SA, as EVP-Business Development & Alliance Management from 2024 to 2025.
Dr. Meyer received her doctorate degree from Johann Wolfgang Goethe-Universität Frankfurt am Main and graduate degree from Yale University.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
INVENTIVA SA 0,02% | 01-03-2025 | 32.519 ( 0,02% ) | 162 607 $ | 31-05-2026 |
Eerdere bekende functies van Kristina Meyer
| Bedrijven | Functie | Einde |
|---|---|---|
| INVENTIVA | Corporate Officer/Principal | 01-07-2025 |
Oxford BioTherapeutics Ltd.
 Oxford BioTherapeutics Ltd. Pharmaceuticals: MajorHealth Technology Develops antibody-based medicines for oncology | Corporate Officer/Principal | 01-01-2015 |
Evotec (UK) Ltd.
 Evotec (UK) Ltd. Miscellaneous Commercial ServicesCommercial Services Provides research and development on natural sciences and engineering | Corporate Officer/Principal | 01-08-2013 |
Sertant, Inc.
 Sertant, Inc. Financial ConglomeratesFinance Operates as development stage company | Corporate Officer/Principal | 01-11-2004 |
Thieme Medical Publishers, Inc.
 Thieme Medical Publishers, Inc. Specialty StoresRetail Trade Engages in retails sales of medical and science books through online | Corporate Officer/Principal | - |
Opleiding van Kristina Meyer
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
14
Eerstegraads connecties
7
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 7 |
|---|---|
Oxford BioTherapeutics Ltd.
Oxford BioTherapeutics Ltd. Pharmaceuticals: MajorHealth Technology Develops antibody-based medicines for oncology | Health Technology |
Sertant, Inc.
Sertant, Inc. Financial ConglomeratesFinance Operates as development stage company | Finance |
Yale University
 Yale University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Johann Wolfgang Goethe-Universität Frankfurt am Main
 Johann Wolfgang Goethe-Universität Frankfurt am Main Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Thieme Medical Publishers, Inc.
Thieme Medical Publishers, Inc. Specialty StoresRetail Trade Engages in retails sales of medical and science books through online | Retail Trade |
Evotec (UK) Ltd.
Evotec (UK) Ltd. Miscellaneous Commercial ServicesCommercial Services Provides research and development on natural sciences and engineering | Commercial Services |
Inventiva SA
 Inventiva SA BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that develops oral small molecule therapies for the treatment of MASH and other diseases | Health Technology |
Kies MarketScreener 
